An interventional study of Phakic Implantable Collamer Lens (ICL) in Myopia and Astigmatism, sponsored by Staar Surgical Company. Not yet recruiting. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by Staar Surgical Company · Not applicable, Interventional, and Treatment
A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.
1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.
This study's planned enrollment of 10 is below the median of 78 across 923 interventional studies indexed under Myopia.
Browse Myopia studies →Staar Surgical Company is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive a phakic implantable collamer lens (ICL) in each eye
Device: Phakic Implantable Collamer Lens (ICL)
Diffractive Trifocal Phakic ICL
Cumulative and Persistent Adverse Events
Safety Population
Time frame: 3 Months
Rates of Secondary Surgical Interventions
Safety Population
Time frame: 3 Months
Frequency and Proportion of Eyes With Visual Symptoms
Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
Time frame: 3 Months
Frequency and Proportion of Eyes With Ocular and Visual Symptoms
Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
Time frame: 3 Months
Uncorrected Distance Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Uncorrected Intermediate Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Uncorrected Near Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Best Corrected Distance Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Distance Corrected Intermediate Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Distance Corrected Near Visual Acuity
Safety Population - Mean Change and Mean Difference
Time frame: 3 Months
Mean Monocular Contrast Sensitivity
Safety Population
Time frame: 3 Months
Defocus Curves from +1.0 D through -3.0 D Defocus
Safety Population
Time frame: 3 Months
Subjective Visual Quality
Safety Population - Visual Symptoms will be captured using a patient reported outcome questionnaire
Time frame: 3 Months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Staar Surgical Company